HUTCHMED (China) HCM
NASDAQ HCM
$12.58 -0.01 (-0.08%)
As of: Aug 20, 2026 · 3:59 PM EDT

HUTCHMED (China) (HCM) Net Cash Flow Growth (3y) (2021)

HUTCHMED (China) (HCM) Net Cash Flow Growth (3y) (2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -28.90%
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -5.41%
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 19.55%
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 95.24%
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -106.21%
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 4.40%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 17.73%
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 HUTCHMED (China) 2.18 Bn 2.18 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2021 153.53%
Mar 31, 2021 27.66%